Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CareDx Inc CDNA

Healthcare Biotechnology
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based... see more

Recent & Breaking News (NDAQ:CDNA)

CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care

Business Wire September 29, 2022

Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions

Business Wire September 27, 2022

CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List

Business Wire September 26, 2022

CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference

Business Wire September 19, 2022

CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone

Business Wire September 14, 2022

CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society

Business Wire September 12, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CareDx, Inc

Newsfile August 30, 2022

CareDx Reports Second Quarter 2022 Results

Business Wire August 4, 2022

CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

Business Wire August 4, 2022

CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care

Business Wire August 2, 2022

CareDx to Report Second Quarter 2022 Financial Results

Business Wire July 28, 2022

CDNA SHAREHOLDER ALERT: Jakubowitz Law Reminds CareDx Shareholders of a Lead Plaintiff Deadline of July 22, 2022

PR Newswire July 22, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2022 in CareDx Lawsuit - CDNA

Newsfile July 21, 2022

CareDx Deadline Alert

Newsfile July 21, 2022

CDNA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving CareDx, Inc

Newsfile July 21, 2022

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CareDx, Inc. (CDNA)

Business Wire July 21, 2022

CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Behalf of CareDx, Inc. Limited Shareholders

Newsfile July 21, 2022

Bronstein, Gewirtz & Grossman, LLC Reminds CareDx, Inc. (CDNA) Shareholders of July 22, 2022 Class Action Deadline and Encourages Investors to Actively Participate

Newsfile July 21, 2022

CDNA FINAL DEADLINE: Hagens Berman, National Trial Attorneys, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys Before July 22nd Application Deadline in Securities Class Action

Newsfile July 21, 2022

Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against CareDx, Inc. (CDNA)

PR Newswire July 21, 2022